Skip to main content
  • Contact Us
  • Careers
  • Quest
  • Research Portal
  • About Us
    • Back
    • Overview
    • Leadership Team
    • Our People, Our Values
    • Global Locations
  • Expertise
    • Back
    • All Expertise
    • Investment Banking
      • Back
      • Overview
      • M&A and Financial Advisory
      • Equity Capital Markets
      • Financial Sponsors
      • Debt Advisory & Restructuring
      • Corporate Broking and Investor Relations (UK)
      • Global Investment Banking Team
    • Research & Strategy
    • Sales & Trading
    • Corporate Access
    • Quest®
  • Sectors
    • Back
    • Overview
    • Blockchain & Digital Assets
    • Business Services
    • Consumer & Retail
    • Energy
    • Financials
    • Healthcare
    • Industrials / Aerospace & Defense
    • Metals & Mining
    • Real Estate & REITS
    • Sustainability
    • Technology
  • Transactions
  • News & Insights
    • Back
    • News
    • Insights
    • Events and Conferences

August 2016

Prism Medical

Prism Medical
US$81m
August 2016 Sweden Flag Canada Flag

Prism Medical

Financial Advisor on its sale to Handicare Group AB

Handicare Group Logo
Healthcare M&A Advisory
Press Releases
  • Prism Medical Ltd. | 8.31.16

More Like This

  • TriSalus
    US$22m
    May 2025 US Flag

    TriSalus

    Sole Placement Agent (PIPE)

    View Transaction Detail

  • Lucid Diagnostics
    US$17m
    April 2025 US Flag

    Lucid Diagnostics

    Sole Bookrunner (Follow-On Offering)

    View Transaction Detail

  • Lucid Diagnostics
    US$15m
    March 2025 US Flag

    Lucid Diagnostics

    Sole Placement Agent (Registered Direct Offering)

    View Transaction Detail

View all Healthcare transactions

CG Websites

  • Australia - Wealth Management
  • Canada - Wealth Management
  • UK & Crown Dependencies – Wealth Management
  • Investor Relations

CONTACT

  • Contact Us
  • Global Locations

STAY IN TOUCH

  • LinkedIn
  • Memberships
  • Privacy Policy
  • Cookie Policy
  • Regulatory & Legal Disclosures
  • Modern Slavery Act Statement
  • CGLLC Relationship Summary

© 2025 Canaccord Genuity Group Inc.